OCTAPHARMA AG based in Lachen, CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-07-10

US20250222079A1

Human necessities

FX ACTIVATION PROCESS AND ITS USE IN THE PREPARATION OF A FXA COMPOSITION

#2 | 2024-12-19

US20240415945A1

Human necessities

C1-ESTERASE INHIBITOR PREPARATION

#3 | 2022-09-29

US20220305089A1

Human necessities

STABILIZING BUFFER FOR FACTOR VIII AND VWF

#4 | 2022-07-28 ✅ Patent 12,233,126 granted on 2025-02-25

US20220233692A1

Human necessities

High concentration immunoglobulin composition for pharmaceutical application

#5 | 2021-09-23 ✅ Patent 12,274,738 granted on 2025-04-15

US20210290738A1

Human necessities

FX activation process and its use in the preparation of a FXa composition

#6 | 2021-09-09 ✅ Patent 11,738,069 granted on 2023-08-29

US20210275644A1

Human necessities

Polypeptides modulating SIGLEC dependent immune responses

#7 | 2021-01-14 ✅ Patent 11,383,002 granted on 2022-07-12

US20210008243A1

Human necessities

Plasma-based films and methods for making and using the same

#8 | 2020-09-24 ✅ Patent 11,383,001 granted on 2022-07-12

US20200297893A1

Human necessities

Plasma-based films and methods for making and using the same

#9 | 2020-03-05 ✅ Patent 12,083,171 granted on 2024-09-10

US20200069780A1

Human necessities

C1-esterase inhibitor preparation

#10 | 2020-01-09 ✅ Patent 10,889,630 granted on 2021-01-12

US20200010532A1

Chemistry; metallurgy

Method of separating Factor VIII from blood products

#11 | 2019-11-28

US20190358301A1

Human necessities

PROTECTING COMPOSITIONS FOR RECOMBINANTLY PRODUCED FACTOR VIII

#12 | 2019-07-04 ✅ Patent 11,013,789 granted on 2021-05-25

US20190201495A1

Human necessities

Polypeptides modulating SIGLEC dependent immune responses

#13 | 2019-06-20 ✅ Patent 11,713,458 granted on 2023-08-01

US20190185848A1

Chemistry; metallurgy

Means and methods for modifying multiple alleles

#14 | 2019-06-06 ✅ Patent 12,171,808 granted on 2024-12-24

US20190169268A1

Chemistry; metallurgy

Glycosylated VWF fusion proteins with improved pharmacokinetics

#15 | 2019-05-02 ✅ Patent 11,191,833 granted on 2021-12-07

US20190125868A1

Human necessities

High concentration immunoglobulin composition for pharmaceutical application

#16 | 2019-01-31

US20190030169A1

Human necessities

STABILIZING AGENT FOR PHARMACEUTICAL PROTEINS

#17 | 2019-01-17 ✅ Patent 11,401,300 granted on 2022-08-02

US20190016755A1

Chemistry; metallurgy

Process for production of fibrinogen and fibrinogen produced thereby

#18 | 2018-07-05 ✅ Patent 10,251,940 granted on 2019-04-09

US20180185455A1

Human necessities

Preparation comprising factor VIII and Von Willebrand factor peptides

#19 | 2018-05-03 ✅ Patent 10,640,548 granted on 2020-05-05

US20180118812A1

Chemistry; metallurgy

Method for inactivation/removal of coagulation factors by precipitation

#20 | 2017-07-06

US20170189494A1

Human necessities

PROTECTING COMPOSITIONS FOR RECOMBINANTLY PRODUCED FACTOR VIII

#21 | 2017-06-29 ✅ Patent 10,626,431 granted on 2020-04-21

US20170183703A1

Chemistry; metallurgy

Method for improved isolation of recombinantly produced proteins

#22 | 2017-06-01 ✅ Patent 9,796,986 granted on 2017-10-24

US20170152523A1

Chemistry; metallurgy

Serum-free stable transfection and production of recombinant human proteins in human cell lines

#23 | 2017-02-23 ✅ Patent 10,214,575 granted on 2019-02-26

US20170051028A1

Chemistry; metallurgy

Process for the purification of a growth factor protein

#24 | 2016-11-24 ✅ Patent 10,822,393 granted on 2020-11-03

US20160340410A1

Chemistry; metallurgy

Process for manufacturing factor VIII having an improved ratio of FVIII:C/FVIII/AG

#25 | 2016-09-15 ✅ Patent 9,938,318 granted on 2018-04-10

US20160264619A1

Chemistry; metallurgy

Process for production of fibrinogen

#26 | 2016-09-08 ✅ Patent 10,098,956 granted on 2018-10-16

US20160256555A1

Human necessities

Stabilizing agent for pharmaceutical proteins

#27 | 2016-06-23 ✅ Patent 9,512,457 granted on 2016-12-06

US20160177362A1

Chemistry; metallurgy

Serum-free stable transfection and production of recombinant human proteins in human cell lines

#28 | 2015-09-10

US20150250879A1

Human necessities

TEST FOR HEMOLYTIC POTENTIAL OF PHARMACEUTICAL PRODUCTS AND FORMULATIONS FOR RISK MINIMIZATION

#29 | 2015-07-30

US20150211064A1

Chemistry; metallurgy

ASSAY AND METHOD FOR THE IDENTIFICATION OF INDIVIDUAL RESPONSIVENESS TO IMMUNOGLOBULIN THERAPY

#30 | 2015-02-12 ✅ Patent 10,112,972 granted on 2018-10-30

US20150045539A1

Chemistry; metallurgy

Process for production of fibrinogen and fibrinogen produced thereby

#31 | 2015-02-12 ✅ Patent 9,273,325 granted on 2016-03-01

US20150044720A1

Chemistry; metallurgy

Serum-free stable transfection and production of recombinant human proteins in human cell lines

#32 | 2014-08-07 ✅ Patent 9,943,600 granted on 2018-04-17

US20140221290A1

Human necessities

Stabilizing agent for pharmaceutical proteins

#33 | 2014-02-20

US20140051839A1

Chemistry; metallurgy

Process for Reduction and/or Removal of FXI and FXIa from Solutions Containing said Coagulation Factors

#34 | 2014-02-20 ✅ Patent 9,115,381 granted on 2015-08-25

US20140051123A1

Chemistry; metallurgy

Method of increasing the productivity of eucaryotic cells in the production of recombinant FVIII

#35 | 2014-01-09 ✅ Patent 9,901,597 granted on 2018-02-27

US20140007547A1

Chemistry; metallurgy

Method for inactivation/removal of coagulation factors by precipitation

#36 | 2013-10-17 ✅ Patent 9,371,355 granted on 2016-06-21

US20130274444A1

Chemistry; metallurgy

Process for production of fibrinogen

#37 | 2013-08-08 ✅ Patent 8,809,510 granted on 2014-08-19

US20130203971A1

Chemistry; metallurgy

Method for purification of complement factor H

#38 | 2013-05-16 ✅ Patent 8,769,841 granted on 2014-07-08

US20130118025A1

Mechanical engineering

Lyophilisation targeting defined residual moisture by limited desorption energy levels

#39 | 2013-04-18 ✅ Patent 9,453,045 granted on 2016-09-27

US20130096279A1

Chemistry; metallurgy

Process for the purification of a growth factor protein

#40 | 2013-03-28

US20130079498A1

Chemistry; metallurgy

PROCESS FOR PURIFYING VITAMIN K DEPENDENT PROTEINS SUCH AS COAGULATION FACTOR IX

#41 | 2011-12-01 ✅ Patent 8,436,142 granted on 2013-05-07

US20110294989A1

Chemistry; metallurgy

Processing of recombinant human G-CSF precursor

#42 | 2011-10-27 ✅ Patent 9,120,873 granted on 2015-09-01

US20110262424A1

Chemistry; metallurgy

Recombinantly produced human factor VIII and IX

#43 | 2011-06-30 ✅ Patent 8,329,871 granted on 2012-12-11

US20110160435A1

Chemistry; metallurgy

Process of purifying coagulation factor VIII

#44 | 2010-08-19 ✅ Patent 9,296,799 granted on 2016-03-29

US20100210821A1

Chemistry; metallurgy

Process for isolation and purification of a target protein free of prion protein (PrP)

#45 | 2010-07-22 ✅ Patent 8,871,439 granted on 2014-10-28

US20100184141A1

Chemistry; metallurgy

Serum-free stable transfection and production of recombinant human proteins in human cell lines

#46 | 2010-06-24 ✅ Patent 8,518,452 granted on 2013-08-27

US20100159023A1

Human necessities

Method for stabilizing blood plasma components in a lyophilizate using carbon dioxide and phosphoric acid

#47 | 2009-09-03 ✅ Patent 8,962,813 granted on 2015-02-24

US20090221491A1

Chemistry; metallurgy

Purification and use of a factor for supporting wound healing

#48 | 2009-04-02 ✅ Patent 9,388,402 granted on 2016-07-12

US20090088370A1

Chemistry; metallurgy

Method for improved isolation of recombinantly produced proteins

#49 | 2008-07-24

US20080172902A1

Mechanical engineering

Lyophilisation targeting defined residual moisture by limited desorption energy levels

#50 | 2007-10-04 ✅ Patent 7,985,846 granted on 2011-07-26

US20070232791A1

Chemistry; metallurgy

Hemostatically active vWF-containing preparation and process for the preparation thereof

#51 | 2007-07-26 ✅ Patent 7,553,938 granted on 2009-06-30

US20070173638A1

Chemistry; metallurgy

Method of providing a purified, virus safe antibody preparation

#52 | 2007-01-23 ✅ Patent 7,166,709 granted on 2007-01-23

US10257375

Haemostatically active preparation containing vWF and method for the production thereof

#53 | 2006-08-31

US20060194300A1

Human necessities

Process for preparing an alpha-1-antitrypsin solution

#54 | 2006-05-11 ✅ Patent 7,700,732 granted on 2010-04-20

US20060100419A1

Human necessities

Prekallikrein depleted plasma derived albumin fraction

#55 | 2005-05-17 ✅ Patent 6,893,856 granted on 2005-05-17

US10136468

Process for preparing virus-inactivated factors 1X and X by membrane chromatography

Also check out OCTAPHARMA AG's (Lachen, Switzerland) applicant profile with 26 patent applications submitted.

AssigneeID:

16155 ⎘